Trademark Search in Canada

HEXAGON AND ARROW DESIGN

View On IC.GC.CA

REGISTERED

on 13 Dec 2024

Last Applicant/ Owned by

Recursion Pharmaceuticals, Inc.

41 South Rio Grande StreetSalt Lake City UT 84101

Serial Number

2255853 filed on 27^th Mar 2023

Registration Number

TMA1276170 registered on 13^th Dec 2024

Registration expiry Date

27^th Mar 2033

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

M5E1G4

HEXAGON AND ARROW DESIGN

Trademark usage description

downloadable or recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials Read More

Vienna Information

24 . 15 . 11

Arrows combined with any other figurative element (except a 24.15.13 and a 24.15.15)Flèches combinées avec un autre élément figuratif (excepté a 24.15.13 et a 24.15.15)

26 . 5 . 2

Two polygons, one inside the other (except 26.5.10 and 26.5.11)Deux polygones, l'un dans l'autre (excepté 26.5.10 et 26.5.11)

26 . 5 . 16

Polygons containing other figurative elementsPolygones contenant d'autres éléments figuratifs

26 . 5 . 24

Polygons with dark surfaces or parts of surfacesPolygones avec surface ou partie de la surface foncée

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

26 . 5 . 26

Polygons with cutout areasPolygones avec des zones découpées

26 . 7 . 19

Quadrilaterals with one or more polygons other than trianglesQuadrilatères avec un ou plusieurs polygones autres que les triangles

24 . 15 . 1

One arrowUne flèche

Classification Information

Class [009]
Downloadable or recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds.

Classification kind code

Class [042]
Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; drug use discovery services; scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (saas) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds.

Classification kind code

Mark Details

Serial Number

2255853

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 27^th Aug 2024	Approval Notice Sent
Submitted for opposition 26 on 27^th Aug 2024	Approved
Submitted for opposition 22 on 19^th Aug 2024	Search Recorded
Submitted for opposition 256 on 4^th Mar 2024	Notification of Possible Opposition Sent
Submitted for opposition 48 on 6^th Jun 2023	Agent Changed
Submitted for opposition 257 on 4^th May 2023	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 3^rd May 2023	Created
Submitted for opposition 31 on 3^rd May 2023	Formalized
Submitted for opposition 228 on 27^th Mar 2023	International Registration
Submitted for opposition 30 on 27^th Mar 2023	Filed